Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin + Pioglitazone in Drug Naive T2D
NCT00101803Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Jan 2005; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00101803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101803.